Pharmaceuticals, Biotechnology and Life Sciences
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.
Premaitha Health PLC welcomes the UK National Screening Committee’s (NSC) recommendation to routinely offer NIPT testing on the NHS to…
Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion (22 billion pound) cash and stock offer, catapulting it to a leading position in treating rare diseases.
Sanofi and Warp Drive Bio have extended and reshaped their existing collaboration utilizing Warp Drive’s proprietary SMART(TM) (Small Molecule Assisted…
SwissRed AG, Murten, has, in collaboration with Biofrontera, received the European CE marking for its IndoorLux illumination system for treatment…
LivaNova said that FDA’s Warning Letter can be resolved without a material impact on financial results.
Glenmark Pharmaceuticals Inc., has been granted tentative approval by the USFDA for its Dronedarone Tablets, 400 mg, the generic version…
Glenmark confirms reaching agreement with Roche over patent disputes
Suven Life Sciences Ltd has announced that the grand of one product patent from Canada, one from ARIPO and one from South Korea corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030.